Arkolith/Insider Trading/QTTB/Form 4

Kalowski Lee

CFO and PresidentQ32 Bio Inc. (QTTB) · full profile →Form 4 · filed Feb 27, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Grant(A)53K—$053K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Grant(A)161K—$0161K
Feb 24, 2025Disposed to issuer(D)161K—$00
Feb 24, 2025Disposed to issuer(D)17K—$00
Feb 24, 2025Grant(A)17K—$017K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-028269) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML